Последние добавленные видео:
NCT03112174
-
1 г. назад
396 1 г. назад 3:28The SYMPATICO trial: ibrutinib plus venetoclax in TP53-mutated MCL
-
2 г. назад
142 2 г. назад 1:43Ongoing clinical trials to look out for in lymphoma
-
5 л. назад
104 5 л. назад 3:18SYMPATICO: safety and efficacy of ibrutinib plus venetoclax for R/R MCL
-
8 л. назад
232 8 л. назад 1:30Final results of the AIM study of ibrutinib and venetoclax in mantle cell lymphoma
-
10 мес. назад
159 10 мес. назад 1:24SYMPATICO: efficacy and safety of ibrutinib plus venetoclax in treatment-naive MCL
-
2 г. назад
148 2 г. назад 2:38Advancing MCL treatment: combination therapies and updates from SYMPATICO
-
2 г. назад
163 2 г. назад 1:52SYMPATICO: Primary analysis results of ibrutinib plus venetoclax for patients with R/R MCL
-
2 г. назад
290 2 г. назад 3:37SYMPATICO: ibrutinib combined with venetoclax in patients with R/R MCL
-
2 г. назад
977 2 г. назад 5:06Trials of interest in the mantle cell lymphoma space at ASH 2023
-
5 л. назад
47 5 л. назад 1:07Exploring Unmet Needs and BTK Inhibitors in the MCL Population
-
10 мес. назад
510 10 мес. назад 2:57Highlights in NHL and CLL from ASCO 2025: key trial updates
-
2 дн. назад
708 2 дн. назад 1:39@member064antiheat NDB 1000ths 18